Cas No.: 1228992-90-2
PRODUCT INFORMATION
Description
Cyclo(RGDfK(Mal)) is a maleimide-modified cyclic pentapeptide designed to mimic extracellular matrix interactions, thereby enhancing cellular adhesion. Its RGD motif targets integrins, while the maleimide group allows for covalent conjugation. It is a critical component for functionalizing advanced 3D biomaterial scaffolds, enabling scalable stem cell culture and controlled expansion under physiologically relevant in vitro conditions.
Molecular Weight
754.79
Purity
> 95%
Formula
C₃₄H₄₆N₁₀O₁₀
Product Type
Targeting Peptide
Sequence
Cyclo[Arg-Gly-Asp-D-Phe-Lys(MAL)]
Form (20 deg.C)
Solid
Storage Condition
Store the product under the recommended conditions in the Certificate of Analysis (CoA).
For Research Use Only | Not For Clinical Use
Related products
- Thrombospondin-1 (1016-1021) (human, Bovine, Mouse) Targeting Peptide (CAT#: OLY-1025-YS-45)
- 3BP-4089 TFA Targeting Peptide (CAT#: OLY-1025-YS-56)
- NGR Targeting Peptide (CAT#: OLY-1025-YS-38)
- Octreotide Targeting Peptide (CAT#: OLY-1025-YS-3)
- Cyclo(Arg-Gly-Asp-D-Phe-Val) TFA Targeting Peptide (CAT#: OLY-1025-YS-51)
- Cyclo(RADfK) Targeting Peptide (CAT#: OLY-1025-YS-61)
- WLSEAGPVVTVRALRGTGSW TFA Targeting Peptide (CAT#: OLY-1025-YS-67)
- GPC3 Targeting Peptide 1 (CAT#: OLY-1025-YS-37)
Online Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.